Hong‐Hao Zhou
- Cancer Research top 1%
- Cancer-related molecular mechanisms research 24
- MicroRNA in disease regulation 9
- Cancer Genomics and Diagnostics 6
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 21
- Molecular Biology top 5%
- RNA modifications and cancer 20
- Epigenetics and DNA Methylation 8
- Circular RNAs in diseases 8
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 10
- Biological Psychiatry top 10%
- Co-authors
- Zhaoqian LiuJi‐Ye YinWei ZhangXi LiRong LiuQiao‐Li LvWei ZhuoLei Hu
- Journals
- PLoS ONE (2 papers)Scientific Reports (3 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- ChinaUnited StatesMalaysia
In The Last Decade
Hong‐Hao Zhou
105 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 131
- Cancer Research 1.2k
- Pharmacology 520
- Molecular Biology 2.1k
- Oncology 569
- Biological Psychiatry 44
Countries citing papers authored by Hong‐Hao Zhou
This map shows the geographic impact of Hong‐Hao Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong‐Hao Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong‐Hao Zhou more than expected).
Fields of papers citing papers by Hong‐Hao Zhou
This network shows the impact of papers produced by Hong‐Hao Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong‐Hao Zhou. The network helps show where Hong‐Hao Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hong‐Hao Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 4 | |
| 3 | 2020 | 7 | |
| 4 | 2020 | 10 | |
| 5 | 2018 | 13 | |
| 6 | 2018 | 44 | |
| 7 | 2018 | 40 | |
| 8 | 2017 | 62 | |
| 9 | 2017 | 29 | |
| 10 | 2017 | 73 | |
| 11 | 2017 | 70 | |
| 12 | 2017 | 83 | |
| 13 | 2017 | 55 | |
| 14 | 2016 | 150 | |
| 15 | 2016 | 25 | |
| 16 | 2014 | 23 | |
| 17 | 2012 | 41 | |
| 18 | 2004 | 50 | |
| 19 | 2003 | 10 | |
| 20 | 2003 | 38 |
About Hong‐Hao Zhou
Hong‐Hao Zhou is a scholar working on Pharmacology, Cancer Research and Biochemistry, having authored 107 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (24 papers), Pharmacogenetics and Drug Metabolism (21 papers), RNA modifications and cancer (20 papers), Drug Transport and Resistance Mechanisms (10 papers), MicroRNA in disease regulation (9 papers), Epigenetics and DNA Methylation (8 papers), Circular RNAs in diseases (8 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Cancer Research (1.2k citations), Pharmacology (520 citations) and Molecular Biology (2.1k citations). Hong‐Hao Zhou has collaborated with scholars based in China, United States and Malaysia. Frequent co-authors include Zhaoqian Liu, Ji‐Ye Yin, Wei Zhang, Xi Li, Rong Liu, Qiao‐Li Lv, Wei Zhuo, Lei Hu, Zhi‐Rong Tan and Weihua Huang. Their work appears in journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.